Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Characterizing Cytokine Biomarker Profiles as a Novel Means of Predicting Sight-Threatening Complications of Retinal Detachment
EF 2020-21
Résumé
Retinal detachment is an ophthalmic emergency affecting approximately 1 in every 10,000 people per year that may lead to blindness if left untreated. Although ophthalmologists are able to repair and restore vision with new advances in surgery, half of all patients will go on to develop complications and subsequent long-term vision loss. Currently, there is very little evidence on how to best detect and prevent these complications. This study aims to develop a new tool to help healthcare providers identify patients with retinal detachment who are at high risk of becoming blind. The tool includes small fluid samples from the eye that are routinely collected during surgery. An analysis of the biomarkers in the eye fluid can show important early signs of any complications. Technologically advanced ophthalmic imaging machines that evaluate microstructural pathologies inside the eye will also be used to assist in determining which eyes have disease and how the disease is progressing over time. This will mean that vision loss can be detected and prevented sooner than was previously possible. Ultimately, this more tailored approach to patient care will improve vision outcomes and reduce disability. A pilot study has been successfully conducted demonstrating the feasibility of carrying out this project. This research will also analyze the direct and indirect healthcare costs of caring for patients with retinal detachment. It will be determined if the use of biomarkers for predicting eye disease have good value for money spent when used by health care providers. A better understanding of the biomarkers and outcomes of patients with retinal detachment will enable researchers and clinicians to develop improved treatment options that target those affected and ultimately decrease the burden of vision loss. Additionally, the findings from this study will help future studies in developing tools that use biomarkers for preventing and treating a variety of other medical conditions.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
437170
Name
Felfeli Tina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Characterizing Cytokine Biomarker Profiles as a Novel Means of Predicting Sight-Threatening Complications of Retinal Detachment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Advanced Imaging Technology; Blindness; Cost-Effectiveness Analysis; Cytokine Biomarkers; Ophthalmology; Patient-Centered Care; Prediction Models; Rhegmatogenous Retinal Detachment; Translational Research; Vision Loss
Abstract
Retinal detachment is an ophthalmic emergency affecting approximately 1 in every 10,000 people per year that may lead to blindness if left untreated. Although ophthalmologists are able to repair and restore vision with new advances in surgery, half of all patients will go on to develop complications and subsequent long-term vision loss. Currently, there is very little evidence on how to best detect and prevent these complications. This study aims to develop a new tool to help healthcare providers identify patients with retinal detachment who are at high risk of becoming blind. The tool includes small fluid samples from the eye that are routinely collected during surgery. An analysis of the biomarkers in the eye fluid can show important early signs of any complications. Technologically advanced ophthalmic imaging machines that evaluate microstructural pathologies inside the eye will also be used to assist in determining which eyes have disease and how the disease is progressing over time. This will mean that vision loss can be detected and prevented sooner than was previously possible. Ultimately, this more tailored approach to patient care will improve vision outcomes and reduce disability. A pilot study has been successfully conducted demonstrating the feasibility of carrying out this project. This research will also analyze the direct and indirect healthcare costs of caring for patients with retinal detachment. It will be determined if the use of biomarkers for predicting eye disease have good value for money spent when used by health care providers. A better understanding of the biomarkers and outcomes of patients with retinal detachment will enable researchers and clinicians to develop improved treatment options that target those affected and ultimately decrease the burden of vision loss. Additionally, the findings from this study will help future studies in developing tools that use biomarkers for preventing and treating a variety of other medical conditions.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Felfeli, Tina
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~